All composite outcomes were significantly greater ( Bonferroni significance level , P@ @ ) with combination therapy ( i.e. infliximab and azathioprine ; @-@ @ % ) vs. azathioprine monotherapy ( @-@ @ % ; p @ for all comparisons ) .